The	the	O	O	O	O
3-week	3-week	O	O	O	O
sulphasalazine	sulphasalazine	CHEMICALS	O	OTHERS	I
syndrome	syndrome	O	O	O	O
strikes	strikes	O	O	O	O
again	again	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
34-year-old	34-year-old	O	O	O	O
lady	lady	O	O	O	O
developed	developed	O	O	O	O
a	a	O	O	O	O
constellation	constellation	O	O	O	O
of	of	O	O	O	O
dermatitis	dermatitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
fever	fever	O	DISEASE	OTHERS	I
,	,	O	O	O	O
lymphadenopathy	lymphadenopathy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
beginning	beginning	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
17th	17th	O	O	O	O
day	day	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
oral	oral	O	O	O	O
sulphasalazine	sulphasalazine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
sero-negative	sero-negative	O	O	O	O
rheumatoid	rheumatoid	O	DISEASE	OTHERS	I
arthritis	arthritis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Cervical	cervical	O	O	O	O
and	and	O	O	O	O
inguinal	inguinal	O	O	O	O
lymph	lymph	O	O	O	O
node	node	O	O	O	O
biopsies	biopsies	O	O	O	O
showed	showed	O	O	O	O
the	the	O	O	O	O
features	features	O	O	O	O
of	of	O	O	O	O
severe	severe	O	O	O	O
necrotising	necrotising	O	O	O	O
lymphadenitis	lymphadenitis	O	O	OTHERS	I
,	,	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
erythrophagocytosis	erythrophagocytosis	O	O	O	O
and	and	O	O	O	O
prominent	prominent	O	O	O	O
eosinophilic	eosinophilic	O	O	OTHERS	I
infiltrates	infiltrates	O	O	O	O
,	,	O	O	O	O
without	without	O	O	O	O
viral	viral	O	O	O	O
inclusion	inclusion	O	O	O	O
bodies	bodies	O	O	O	O
,	,	O	O	O	O
suggestive	suggestive	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
adverse	adverse	O	O	OTHERS	I
drug	drug	O	O	OTHERS	I
reaction	reaction	O	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
week	week	O	O	O	O
later	later	O	O	O	O
,	,	O	O	O	O
fulminant	fulminant	O	O	O	O
drug-induced	drug-induced	O	O	O	O
hepatitis	hepatitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
anti-nuclear	anti-nuclear	O	O	O	O
autoantibodies	autoantibodies	O	O	O	O
(	(	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
with	with	O	O	O	O
other	other	O	O	O	O
markers	markers	O	O	O	O
of	of	O	O	O	O
autoimmunity	autoimmunity	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
multi-organ	multi-organ	O	O	O	O
failure	failure	O	O	O	O
and	and	O	O	O	O
sepsis	sepsis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
supervened	supervened	O	O	O	O
.	.	O	O	O	O

She	she	O	O	O	O
subsequently	subsequently	O	O	O	O
died	died	O	O	O	O
some	some	O	O	O	O
5	5	O	O	O	O
weeks	weeks	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
commencement	commencement	O	O	O	O
of	of	O	O	O	O
her	her	O	O	O	O
drug	drug	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Post-mortem	post-mortem	O	O	O	O
examination	examination	O	O	O	O
showed	showed	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
massive	massive	O	O	OTHERS	I
hepatocellular	hepatocellular	O	O	OTHERS	I
necrosis	necrosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
acute	acute	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
focal	focal	O	O	O	O
acute	acute	O	O	O	O
tubulo-interstitial	tubulo-interstitial	O	O	O	O
nephritis	nephritis	O	O	OTHERS	I
and	and	O	O	O	O
extensive	extensive	O	O	O	O
bone	bone	O	O	OTHERS	I
marrow	marrow	O	O	OTHERS	I
necrosis	necrosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
no	no	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
malignancy	malignancy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
thought	thought	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
clinico-pathological	clinico-pathological	O	O	O	O
features	features	O	O	O	O
and	and	O	O	O	O
chronology	chronology	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
case	case	O	O	O	O
bore	bore	O	O	O	O
the	the	O	O	O	O
hallmarks	hallmarks	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
so-called	so-called	O	O	O	O
"	"	O	O	O	O
3-week	3-week	O	O	O	O
sulphasalazine	sulphasalazine	CHEMICALS	O	OTHERS	I
syndrome	syndrome	O	O	O	O
"	"	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
rare	rare	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
often	often	O	O	O	O
fatal	fatal	O	O	O	O
,	,	O	O	O	O
immunoallergic	immunoallergic	O	O	O	O
reaction	reaction	O	O	O	O
to	to	O	O	O	O
sulphasalazine	sulphasalazine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

